Laborgemeinschaft für Haematologie und Onkologie GmbH (LGHO) is a manufacturing facility approved under §13 AMG for patient-individual parenteral preparations in oncology. On behalf of various pharmacies, LGHO produces prescription medicines and operates four safety workbenches. In the 2021 fiscal year LGHO prepared 42,180 infusions and generated revenue of €50.3 million. The company is primarily active in eastern Germany but also supplies outpatient practices in other federal states. In addition, LGHO expanded a pharmaceutical wholesale business in 2021 and recorded its first significant economic successes there.
ist die Führung eines Laborbetriebs zur Herstellung patientenindividueller Zubereitungsrezepturen im onkologischen und ophthalmologischen Umfeld.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Leipzig Local Court, HRB 24104 (as of 23 September 2026)
Source: German Commercial Register (Handelsregister) Leipzig Local Court, HRB 24104 (as of 23 September 2026)
Source: German Commercial Register (Handelsregister) Leipzig Local Court, HRB 24104 (as of 23 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Leipzig Local Court, HRB 24104 (as of 23 September 2026)
EurimPharm Arzneimittel GmbH
Saaldorf-Surheim · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
SymbioPharm GmbH
Herborn · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Medios Solutions Bonn GmbH
Bonn · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sign in to view detailed salary and cost trends.
